Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic targeting of neuroblastoma, an update

14 Dec 2024

Abstract excerpt

Neuroblastoma is a paediatric cancer of the sympathetic nervous system that originates from the neural crest and can be categorised into stages and risk groups. Risk groups inform treatment options and high-risk cases bear a 50 % probability of relapse post-treatment remission. In neuroblastoma, MYCN amplification is the strongest predictor of unfavourable patient prognosis; circa 50 % of high-risk cases display...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer therapeutics and mechanisms
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39681211
DOI: 10.1016/j.canlet.2024.217393

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic targeting of neuroblastoma, an updatePMID 39681211Read ↗

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastomaSemantic proximity Read ↗

MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting NeuroblastomaSemantic proximity Read ↗

Metabolic protein kinase signalling in neuroblastomaSemantic proximity Read ↗

Polyamine Metabolism Is Sensitive to Glycolysis Inhibition in Human Neuroblastoma CellsSemantic proximity Read ↗

Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastomaSemantic proximity Read ↗

Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastomaSemantic proximity Read ↗

Amino Acid Metabolism Subtypes in Neuroblastoma Identifying Distinct Prognosis and Therapeutic Vulnerabilities.Semantic proximity Read ↗

N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaSemantic proximity Read ↗

Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastomaSemantic proximity Read ↗

Uncovering novel therapeutic targets in glucose, nucleotides and lipids metabolism during cancer and neurological diseasesSemantic proximity Read ↗

Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN ‐amplified neuroblastomaSemantic proximity Read ↗

MYCN Amplifications and Metabolic Rewiring in NeuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.